Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial
Author(s):
Rousel, J. (0000-0003-0986-3753); Bergmans, M.E.; Meulen, L.W.J. van der; Pagan, L.; Bruin, D.T. de; Kam, M.L. de; Klarenbeek, N.B.; Bouwstra, J.A. (0000-0002-7123-6868); Seyger, M.M.B.; Reek, J.M.P.A. van den; Niemeyer-van der Kolk, T.; Rissmann, R.; Doorn, M.B.A. van; NGID consortium
Published
2023
Publication type
Article / Letter to editor
Date issued
2023-10-05
Language
English
Is part of
Journal of The American Academy of Dermatology (2023), Vol. 90, no. 2, p. 395-397
